Maersk-Moller Kimberly 4
4 · MIMEDX GROUP, INC. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Maersk-Moller Kimberly
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-02-28$8.40/sh−2,111$17,743→ 265,271 total - Award
Common Stock
2025-03-03+45,929→ 314,942 total - Award
Stock Options
2025-03-03+36,486→ 75,794 totalExercise: $8.30Exp: 2032-03-03→ Common Stock (36,486 underlying)
Footnotes (4)
- [F1]The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
- [F2]Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
- [F3]Includes an aggregate of 3,742 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.
- [F4]The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.